VBLT - Vascular Biogenics Ltd. VBLT) CEO Dror Harats on Q3 2019 Results - Earnings Call Transcript
Vascular Biogenics Ltd. (VBLT)
Q3 2019 Earnings Conference Call
November 12, 2019 10:00 a.m. ET
Executives
Dror Harats - CEO
Amos Ron - CFO
Michael Wood - IR, LifeSci Advisors
Analysts
Geulah Livshits - Chardan
Arthur Yu He - H.C. Wainwright
Soumit Roy - Jones Trading
Sam Slutsky - LifeSci Capital
Presentation
Operator
Greetings and welcome to the VBL Therapeutics Third Quarter 2019 Earnings Call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. [Operator instructions]. As a reminder, this conference is being